Laliberte v. BASF Bioresearch Co.

337 F. Supp. 2d 271, 2004 U.S. Dist. LEXIS 20128, 2004 WL 2181595
CourtDistrict Court, D. Massachusetts
DecidedAugust 13, 2004
DocketCIV.A.01-40141-NMG
StatusPublished

This text of 337 F. Supp. 2d 271 (Laliberte v. BASF Bioresearch Co.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Laliberte v. BASF Bioresearch Co., 337 F. Supp. 2d 271, 2004 U.S. Dist. LEXIS 20128, 2004 WL 2181595 (D. Mass. 2004).

Opinion

MEMORANDUM & ORDER

GORTON, District Judge.

This case arises from a claim of disability discrimination under the Americans with Disabilities Act (“ADA”), the Family and Medical Leave Act (“FMLA”) and Massachusetts General Laws Chapter 151B (“Chapter 151B”). Pending before the Court is a motion for summary judgment by defendants BASF Bioresearch Corporation, Abbott Laboratories and Abbott Bioresearch Center (hereafter collectively “BASF” or “Defendants”). 1 Plaintiff, Paula Laliberte (“Laliberte”) opposes the motion.

I. Factual Background

According to the Defendants, in December of 1999 Laliberte was employed as Animal Resources Operations Manager of the Bioresources Department at BASF. Around that time BASF hired veterinarian Dr. Sonya McCathey (“McCathey”) to head that department, which made McCathey Plaintiffs supervisor.

McCathey noted that Laliberte had difficulty fulfilling her job responsibilities, particularly that she failed to report information in a timely manner, failed to perform oversight functions assigned to her, resisted in performing tasks and was disruptive in departmental meetings. McCathey attempted to counsel Plaintiff regarding her job performance but after several meetings McCathey noticed no improvement. BASF then ordered Laliberte to attend Employee Assistance Plan Counseling (“EAPC”).

Noticing no change in Laliberte’s professional manner or ability to perform her job responsibilities after she began EAPC, BASF then required Plaintiff to take a leave of absence. On January 14, 2000, she started a paid leave pursuant to BASF’s short-term disability policy. At that time McCathey expected that Plaintiff would return to work and become a contributing member of the department. Laliberte did not request FMLA leave and BASF did not consider Plaintiffs leave to be under the FMLA.

While Laliberte was on leave, McCathey interviewed all department personnel in order to gain an understanding of the department and how it functioned. She learned from those interviews that several employees thought Plaintiff behaved inappropriately, was hostile and resistant to change and was responsible for creating a demoralized atmosphere within the department. One employee, Lilia Nickerson, stated that Plaintiff had twice informed her that her position in the department was going to be eliminated which was untrue and caused Nickerson severe anxiety.

After concluding the interviews, McCathey prepared Plaintiffs required annual review. Based upon McCathey’s own observations as well as the interviews of other employees, the review documented her poor job performance. After determining that: 1) there were few, if any, responsibilities associated with Laliberte’s position, 2) the department could function without that position and 3) her return to the department would destroy the improving departmental morale, McCathey decided to terminate Plaintiffs employment.

*273 Laliberte was scheduled to return to work on a part-time basis on May 17, 2000. McCathey and BASF Human Resources employee Pamela Barney (“Barney”) scheduled a meeting with Plaintiff. They informed her that her employment was being terminated for the reasons stated in her annual review. Laliberte became upset and left the meeting before McCathey and Barney were able to go over the contents of the review with her. Laliberte’s position was never filled and has been eliminated.

On July 6, 2000, less than two months after her employment at BASF ended, Laliberte obtained a position at Stenton, a Providence, Rhode Island company where she is currently employed, with similar responsibilities to those she had held at BASF. Until she was diagnosed with breast cancer while employed at Stenton, Plaintiff neither requested nor received any accommodations in order to fulfill her job responsibilities.

Plaintiff disputes Defendants’ version of the facts. She claims that she was employed by BASF for 11 years before she was terminated. She maintains that while at BASF she suffered from severe medical impairments, including, but not limited to, severe depression, which restricted her ability to perform major life tasks and that BASF was fully aware of her medical condition.

Laliberte states that in January, 2000 McCathey perceived Laliberte as suffering from a medical impairment and accordingly ordered that she should attend EAPC. After attending EAPC Plaintiff requested reasonable accommodation for her disability, specifically that her tasks and assignments be reduced to writing. She received no accommodation. On January 13, 2000, the EAPC referral source informed BASF that Laliberte was unable to work in her position, due to stress. Defendants knew that Laliberte had been found by their own disability insurance carrier to be disabled from work due to a medical condition. At or about that time Laliberte took leave of absence due to her medical impairment.

While Laliberte was on medical leave no one made any effort to contact her about any alleged workplace issues regarding her performance. During her medical leave of absence, she was issued the first negative evaluation of her career. She contends that she was not fired for any conduct pre-dating her medical problems but because she intended to return to work following her medical leave. She maintains that when she attempted to return to work on May 18, 2000, her position had not been eliminated. She also contends that McCathey’s performance review was false and based upon fabricated complaints.

Laliberte maintains that when she returned to work she was treated differently from other employees. She was removed from the company’s email and voice mail systems. Her professional and personal belongings were removed form her office. Her name was also removed from all signs in her department. She was not given an opportunity to correct any misstatements in her performance review. On or about May 18, 2000, she was discharged purportedly because of her negative performance review. She maintains that BASF has a progressive disciplinary system to which she was not allowed to resort.

Prior to her discharge Laliberte had never had any disciplinary problems at BASF. She disputes the veracity and accuracy of the notes made by McCathey indicating that employees complained about her performance and demeanor. She states that she has affidavits of fellow employees to the effect that they never made negative comments about her to McCath-ey.

*274 Laliberte claims that her medical problems, including tinnitus, memory lapses, headaches, panic attacks, trouble sleeping, and shortness of breath were apparent to everyone. The EAP Coordinator testified that he was informed that Laliberte’s job was “protected.” Her treating psychiatrist, Dr. Richard Tomb, had diagnosed her with Post-Traumatic Stress Disorder, severe anxiety and depression, physical or mental impairments which substantially limit one or more of her major life activities. She maintains that she was fired because of this medical problem rather than for any alleged performance problems.

II. Procedural Background

On August 2, 2001, Laliberte filed the instant action, claiming violation of the ADA, Chapter 151B, and the FMLA.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Hodgens v. General Dynamics Corp.
144 F.3d 151 (First Circuit, 1998)
Criado v. IBM Corporation
145 F.3d 437 (First Circuit, 1998)
Tardie v. Rehabilitation Hospital
168 F.3d 538 (First Circuit, 1999)
Bishop v. Bell Atlantic Corp.
299 F.3d 53 (First Circuit, 2002)
Benoit v. Technical Manufacturing Corp.
331 F.3d 166 (First Circuit, 2003)
Milissa Garside v. Osco Drug, Inc.
895 F.2d 46 (First Circuit, 1990)
Samuel Mesnick v. General Electric Company
950 F.2d 816 (First Circuit, 1991)
Patrick J. O'COnnOr v. Robert W. Steeves
994 F.2d 905 (First Circuit, 1993)
Myrtle Thomas v. Eastman Kodak Company
183 F.3d 38 (First Circuit, 1999)
Reeves v. Sanderson Plumbing Products, Inc.
530 U.S. 133 (Supreme Court, 2000)
Pakizegi v. First Nat. Bank of Boston
831 F. Supp. 901 (D. Massachusetts, 1993)
Wheelock College v. Massachusetts Commission Against Discrimination
355 N.E.2d 309 (Massachusetts Supreme Judicial Court, 1976)
Barry v. Wing Memorial Hospital
142 F. Supp. 2d 161 (D. Massachusetts, 2001)
Nelson v. City of Cranston Ex Rel. McAteer
116 F. Supp. 2d 260 (D. Rhode Island, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
337 F. Supp. 2d 271, 2004 U.S. Dist. LEXIS 20128, 2004 WL 2181595, Counsel Stack Legal Research, https://law.counselstack.com/opinion/laliberte-v-basf-bioresearch-co-mad-2004.